Publications by authors named "Mathew J Ellis"

Claim this Profile
S
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Sara M Tolaney, Hao Guo, Sonia Pernas, William T Barry, Deborah A Dillon, Mathew J Ellis

J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of the proteinuria induced by Rho GTPases.
Liming Wang, Mathew J Ellis, Jose A Gomez, William Eisner, Walter Fennell

Kidney Int· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.
Liming Wang, Mathew J Ellis, Timothy A Fields, David N Howell, Robert F Spurney

Kidney Blood Press Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.
G Thomas Budd, Massimo Cristofanilli, Mathew J Ellis, Allison Stopeck, Ernest Borden

Clin Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.
Massimo Cristofanilli, Daniel F Hayes, G Thomas Budd, Mathew J Ellis, Alison Stopeck

J Clin Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
Harold J Burstein, Lyndsay N Harris, P Kelly Marcom, Rosemary Lambert-Falls, Kathleen Havlin, Mathew J Ellis

J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.
Vered Stearns, Baljit Singh, Theodore Tsangaris, Jeanette G Crawford, Antonella Novielli, Mathew J Ellis

Clin Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis